SARC SARC exists to provide a collaborative platform to make progress in the prevention, diagnosis, and treatment of sarcoma.
SARC has received 9 grants from 7 known foundation funders. Revenue decreased from $3,705,576 in 2023 to $2,780,009 in 2024. Most recent reported revenue: $2,780,009.
Annual Revenue
$2,780,009
Known Funders
7
Grants Received
9
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $2,780,009 | $3,522,270 | $3,914,887 |
| 2023 | $3,705,576 | $3,466,626 | $4,647,616 |
| 2022 | $3,308,156 | $3,523,580 | $4,435,160 |
| 2021 | $2,975,322 | $3,871,934 | $4,576,741 |
| 2020 | $2,628,542 | $3,627,831 | $7,324,171 |
| 2019 | $4,429,424 | $3,243,139 | $8,183,005 |
| 2018 | $4,026,485 | $4,328,308 | $6,819,408 |
| 2017 | $3,572,031 | $4,519,582 | $7,059,071 |
Top Funders
DENVER, CO
WAYNE, NJ
DETROIT, MI
DETROIT, MI
DALLAS, TX
DENVER, CO
Tulsa, OK
CASTLE ROCK, CO
SEATTLE, WA
Key Personnel
From 2024 IRS 990 filing
Steven Young
President & CEO
Ernest Conrad
Board Chair
John Hopper
Treasurer
Eva Gallagher
Secretary
Ann Graham
Board Member
Timothy Timmerman
Board Member
Andrew Wagner
Board Member
Thomas Williams
Board Member
Marlene Portnoy
Former Board Member
Claudia Hill
Chief Operating Officer
Frequently Asked Questions
Other Nonprofits in Michigan
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.